Skip to main content

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

KYNB holding history

Kyntra Bio, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYNB overviewAll 13F holders of KYNBFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KYNB by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1−100.0%Sold outHolders
Q1 20261$7<0.1%00.0%UnchangedHolders
Q4 20251$9<0.1%00.0%UnchangedHolders
Q3 20251$12<0.1%00.0%UnchangedHolders
Q2 20251$5<0.1%−0−13.8%ReducedConverted for a 1-for-25 splitHolders
Q1 202529$9<0.1%00.0%UnchangedHolders
Q4 202429$15<0.1%−8,415−99.7%ReducedHolders
Q3 20248,444$3.37K<0.1%−1,600−15.9%ReducedHolders
Q2 202410,044$8.96K<0.1%00.0%UnchangedHolders
Q1 202410,044$23.6K<0.1%−892−8.2%ReducedHolders
Q4 202310,936$9.69K<0.1%+10,358+1,792.0%AddedHolders
Q3 2023578$499<0.1%−76−11.6%ReducedHolders
Q2 2023654$1.77K<0.1%−66−9.2%ReducedHolders
Q1 2023720$13.4K<0.1%00.0%UnchangedHolders
Q4 2022720$11.5K<0.1%−386−34.9%ReducedHolders
Q3 20221,106$14.0K<0.1%−26−2.3%ReducedHolders
Q2 20221,132$12.0K<0.1%−188−14.2%ReducedHolders
Q1 20221,320$16.0K<0.1%−1,460−52.5%ReducedHolders
Q4 20212,780$40.0K<0.1%−228−7.6%ReducedHolders
Q3 20213,008$31.0K<0.1%−137−4.4%ReducedHolders
Q2 20213,145$84.0K<0.1%−10,438−76.8%ReducedHolders
Q1 202113,583$472.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.